(19)
(11) EP 1 165 776 A1

(12)

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00910250.0

(22) Date of filing: 18.02.2000
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/47, G01N 33/566, A61K 38/17, C07K 16/28, A61K 39/395, C12N 15/62
(86) International application number:
PCT/US0004/326
(87) International publication number:
WO 0050/589 (31.08.2000 Gazette 2000/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 22.02.1999 US 121170 P
08.10.1999 US 158566 P

(71) Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH
New York, New York 10158 (US)

(72) Inventors:
  • CHIARI, Rita
    B-1200 Brussels (BE)
  • COULIE, Pierre
    B-1200 Brussels (BE)
  • BOON-FALLEUR, Thierry
    B-1200 Brussels (BE)

(74) Representative: Harrison Goddard Foote 
Belgrave Hall Belgrave Street
Leeds LS2 8DD
Leeds LS2 8DD (GB)

   


(54) TYROSINE KINASE RECEPTOR EphA3 ANTIGENIC PEPTIDES